Modified Opioid Peptides That Block Pain's Excitatory Side and Boost Relief | Research

The takeaway

Modified dynorphin and beta-endorphin peptides selectively blocked excitatory opioid receptor functions, dramatically enhancing the pain-relieving effects of opioid drugs.

Picomolar potency
Modified opioid peptides blocked excitatory functions at extremely low concentrations, enhancing pain relief

What the researchers found

N- or C-terminus modified dynorphin and beta-endorphin selectively blocked excitatory opioid receptor functions, dramatically enhancing the pain-relieving effects of opioid agonists.

Why it matters

If the excitatory opioid function can be selectively blocked, opioid pain relief could be greatly enhanced with lower doses, potentially reducing side effects and addiction risk.

How the study worked

Mouse dorsal root ganglion (DRG) sensory neurons in culture. Calcium-dependent action potential duration measured as an index of excitatory vs. inhibitory opioid effects. Modified peptides tested for selective blockade.

What this study cannot tell us

In vitro study in cultured mouse sensory neurons. The bimodal opioid receptor concept is not universally accepted. Translation to whole-animal or human pain treatment is uncertain.

How to read the evidence

Moderate — controlled in vitro electrophysiology study with clear dose-response data, though the bimodal opioid receptor concept remains debated.

When this study was published

Published in 1995. The bimodal opioid receptor theory has generated both supporting evidence and controversy. Some modified peptides based on this concept have entered clinical development.

The bigger picture

If the excitatory side of opioid receptors can be selectively blocked, patients might need far lower doses of opioid painkillers — potentially reducing addiction risk, side effects, and overdose deaths while maintaining or improving pain relief.

Questions still open

Can this excitatory opioid blockade approach be translated into clinically usable drugs?
Would chronic blockade of excitatory opioid functions prevent tolerance development?

Common questions

How can opioids both cause and relieve pain?

Opioid receptors appear to have two modes: at very low doses they can excite pain neurons (making pain worse), while at higher doses they inhibit them (relieving pain). This dual nature may contribute to opioid tolerance.

Could this lead to safer painkillers?

Potentially. If the excitatory opioid function is blocked first, much lower doses of opioids produce strong pain relief. Lower doses could mean less addiction risk and fewer side effects.

Read the original research

Specific N- or C-terminus modified dynorphin and beta-endorphin peptides can selectively block excitatory opioid receptor functions in sensory neurons and unmask potent inhibitory effects of opioid agonists.

Brain research, 673(1), 30-8

View on PubMed ↗

Citation

Shen, K F; Crain, S M. (1995). Specific N- or C-terminus modified dynorphin and beta-endorphin peptides can selectively block excitatory opioid receptor functions in sensory neurons and unmask potent inhibitory effects of opioid agonists.. Brain research, 673(1), 30-8.